Cite
HARVARD Citation
Daperno, M. et al. (n.d.). P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION. Digestive and liver disease. 50 (2), pp. e192-e193. [Online].